Kintara Therapeutics (NASDAQ:KTRA)' Saiid Zarrabian and Robert Hoffman joined Proactive to discuss the change of leadership the biopharmaceutical company recently announced.
Hoffman, the company's Chairman, will succeed Zarrabian as President and CEO, while Zarrabian will transition to his new role as Kintara's Head of Strategic Partnerships, and will remain a member of the Board of Directors.